← Leaderboards
Victor Marquez
Basic Sciences
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Basic Sciences
Same institution · by research overlap
Others in their field
Top investigators on “Drug Design /Synthesis /Production”
- Dennis L. Kasper · Harvard Medical School$26,605,444
- Myron Max Levine · University Of Maryland Baltimore$22,074,862
- George R Painter · Chimerix, Inc.$19,230,662
- Donald L Fine · Dynport Vaccine Company, Llc$9,996,228
- Dennis E. Hruby · Oregon State University$9,654,233
- William C Olson · Progenics Pharmaceuticals, Inc.$8,361,679
Research focus
Drug Design /Synthesis /ProductionAntineoplasticsAntiviral AgentsAntiaids AgentEnzyme InhibitorsStereochemistryConformationNuclear Magnetic Resonance SpectroscopyComputer SimulationNucleosidesNucleoside AnalogProdrugsProtein Kinase CPhosphotransferasesBiomedical FacilityEnzyme ActivityDiacylglycerolsChemical StructureChemical SubstitutionDrug Screening /EvaluationChemical Structure FunctionMolecular DynamicsCells2'3'Dideoxynucleoside
Grant awards (35)
Dideoxynucleosides as Potential Anti-AIDS Drugs$253,718
Z01 · FY2008 · CA · contact PI
Carbocyclic Nucleoside Isosteres as Potential Antitumor and Antiviral Agents$253,718
Z01 · FY2008 · CA · contact PI
Enzyme Inhibitors as Potential Anticancer and Antiviral Drugs$508,417
Z01 · FY2007 · CA · contact PI
Carbocyclic Nucleoside Isosteres as Potential Antitumor and Antiviral Agents$381,313
Z01 · FY2007 · CA · contact PI
Dideoxynucleosides as Potential Anti-AIDS Drugs$381,313
Z01 · FY2007 · CA · contact PI
Dideoxynucleosides as Potential Anti-AIDS Drugs$0
Z01 · FY2006 · BC · contact PI
Enzyme Inhibitors as Potential Anticancer and Antiviral$0
Z01 · FY2006 · BC · contact PI
Carbocyclic Nucleoside Isosteres as Potential Antitumor$0
Z01 · FY2006 · BC · contact PI
Carbocyclic Nucleoside Isosteres as Potential Antitumor$0
Z01 · FY2005 · BC
Enzyme Inhibitors as Potential Anticancer and Antiviral$0
Z01 · FY2005 · BC
Dideoxynucleosides as Potential Anti-AIDS Drugs$0
Z01 · FY2005 · BC
Carbocyclic Nucleoside Isosteres as Potential Antitumor$0
Z01 · FY2004 · BC
Dideoxynucleosides as Potential Anti-AIDS Drugs$0
Z01 · FY2004 · BC
Enzyme Inhibitors as Potential Anticancer and Antiviral$0
Z01 · FY2004 · BC
Analysis of Tn-binding Antibody and Lectin Specificity$0
Z01 · FY2004 · BC
Carbocyclic Nucleoside Isosteres as Potential Antitumor$0
Z01 · FY2003 · BC
Enzyme Inhibitors as Potential Anticancer and Antiviral$0
Z01 · FY2003 · BC
Dideoxynucleosides as Potential Anti-AIDS Drugs$0
Z01 · FY2003 · BC
Computer-Aided Drug Design (CADD) Group Project: HIV Int$0
Z01 · FY2002 · BC
Dideoxynucleosides as Potential Anti-AIDS Drugs$0
Z01 · FY2002 · BC
Enzyme Inhibitors as Potential Anticancer and Antiviral$0
Z01 · FY2002 · BC
Carbocyclic Nucleoside Isosteres as Potential Antitumor$0
Z01 · FY2002 · BC
Computer-Aided Drug Design (CADD) Group Project: The Ope$0
Z01 · FY2002 · BC
Dideoxynucleosides as Potential Anti-AIDS Drugs$0
Z01 · FY2001 · BC
NMR Core Facility Proj. /Structure of Nucleic Acid Comp.$0
Z01 · FY2001 · BC
Computer-Aided Drug Design--Open NCI Database$0
Z01 · FY2001 · BC
Carbocyclic Nucleoside Isosteres as Potential Antitumor$0
Z01 · FY2001 · BC
Computer-Aided Drug Design: HIV Integrase Modeling$0
Z01 · FY2001 · BC
Enzyme Inhibitors as Potential Anticancer and Antiviral$0
Z01 · FY2001 · BC
COMPUTER-AIDED DRUG DESIGN MINICORE FACILITY PROJECT$0
Z01 · FY2000 · BC
COMPUTER-AIDED DRUG DESIGN MINICORE FACILITY PROJECT$0
Z01 · FY2000 · BC
Carbocyclic Nucleoside Isosteres as Potential Antitumor and Antiviral Agents$0
Z01 · FY2000 · BC
Enzyme Inhibitors as Potential Anticancer and Antiviral Drugs$0
Z01 · FY2000 · BC
STRUCTURAL ANALYSIS OF NUCLEIC ACID COMPONENTS BY NMR$0
Z01 · FY2000 · BC
Dideoxynucleosides as Potential Anti-AIDS Drugs$0
Z01 · FY2000 · BC